本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

武田制药

15.02
-0.0500-0.33%
盘后14.84-0.1800-1.20%19:28 EDT
成交量:211.31万
成交额:3,175.51万
市值:469.18亿
市盈率:66.91
高:15.10
开:15.03
低:14.93
收:15.07
数据加载中...
2023/02/03

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/08/05

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/07/06

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/06/29

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/06/29

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2022/05/09

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2022/04/21

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2022/02/04

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/01/14

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/01/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/01/14

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/11/12

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/10/28

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/10/25

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/10/18

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/09/14

超过5%披露

TAKEDA PHARMACEUTICAL CO LTD
2021/09/14

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/08/30

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/06/29

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/04/06

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership